Maynard Um
-
-
-
-
-
-
-
Fortress Biotech (FBIO) PT Lowered to $17 at H.C. Wainwright
-
-
-
-
-
-
-
Fortress Biotech (FBIO) Misses Q1 EPS by 48c
-
-
-
-
-
-
-
Fortress Biotech (FBIO) and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101
-
-
-
-
-
-
-
Fortress Biotech (FBIO) Files for 6.19M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
Fortress Biotech (FBIO) Files for 2.35M Share Offering by Selling Stockholders
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

